William Chou, MD

William Chou, MD, president and chief executive officer of Passage Bio, discussed feedback from a recent Type C meeting with the FDA.

William Chou, MD, president and chief executive officer of Passage Bio, discussed feedback from a recent Type C meeting with the FDA.

The president and chief executive officer of Passage Bio discussed feedback from a recent Type C meeting with the FDA.

The president and chief executive officer of Passage Bio discussed feedback from a recent Type C meeting with the FDA.